These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30259646)

  • 41. [Clinical analysis of haploidentical or unrelated donor hematopoietic stem cell transplantation for patients with severe aplastic anemia].
    Chen HR; Lou JX; Zhang Y; Liu XD; Yang K; Chen P; Liu B; He XP; Guo Z; Liu D
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):959-64. PubMed ID: 22931664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Allogeneic hematopoietic stem cell transplantation for acute myeloblastic leukemia in first remission].
    Bondarenko SN; Semenova EV; Vavilov VN; Stancheva NV; Morozova EV; Alianskiĭ AL; Babenko EV; Osipova NÉ; Zubarovskaia LS; Afanas'ev BV
    Ter Arkh; 2013; 85(7):18-25. PubMed ID: 24137943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Allogeneic hematopoietic stem cell transplantations].
    Michallet M
    Transfus Clin Biol; 2011 Apr; 18(2):235-45. PubMed ID: 21466967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases.
    Stenger EO; Chiang KY; Haight A; Qayed M; Kean L; Horan J
    Biol Blood Marrow Transplant; 2015 Oct; 21(10):1845-52. PubMed ID: 26095669
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the European Group for Blood and Marrow Transplant Chronic Malignancies Working Party.
    Sobh M; Michallet M; Dubois V; Iacobelli S; Koster L; Van Biezen A; Fegueux N; Tabrizi R; Finke J; El-Cheikh J; Schipperus M; Meijer E; von dem Borne P; Petersen E; Russell N; Tholouli E; Passweg J; Garban F; Maertens J; Chevalier P; Maillard N; Volin L; Francois S; Lioure B; Beguin Y; Gluckman E; Ruggeri A; Garderet L; Kröger N
    Haematologica; 2017 Jul; 102(7):e271-e274. PubMed ID: 28428268
    [No Abstract]   [Full Text] [Related]  

  • 46. Age does not matter: Mobilization and harvesting are safe and effective for elderly allogeneic peripheral hematopoietic stem cell donors.
    Ocakci S; Kahraman S; Cagirgan S
    Transfus Apher Sci; 2017 Dec; 56(6):825-828. PubMed ID: 29153310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retinal findings and a novel TINF2 mutation in Revesz syndrome: Clinical and molecular correlations with pediatric retinal vasculopathies.
    Gupta MP; Talcott KE; Kim DY; Agarwal S; Mukai S
    Ophthalmic Genet; 2017; 38(1):51-60. PubMed ID: 28095086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hoyeraal-Hreidarsson syndrome: magnetic resonance imaging findings.
    Kuwashima S
    Jpn J Radiol; 2009 Oct; 27(8):324-7. PubMed ID: 19856229
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
    Kröger N; Schetelig J; Zabelina T; Krüger W; Renges H; Stute N; Schrum J; Kabisch H; Siegert W; Zander AR
    Bone Marrow Transplant; 2001 Oct; 28(7):643-7. PubMed ID: 11704786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
    Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
    Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Similar outcomes of allogeneic hematopoietic cell transplantation from unrelated donor and umbilical cord blood vs. sibling donor for pediatric acute myeloid leukemia: Multicenter experience in China.
    Tang X; Chen J; Fang J; Sun X; Qin MQ; Li J; Zhu Y; Luan Z
    Pediatr Transplant; 2015 Jun; 19(4):413-21. PubMed ID: 25903451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies.
    El-Cheikh J; Crocchiolo R; Furst S; Bramanti S; Sarina B; Granata A; Vai A; Lemarie C; Faucher C; Mohty B; Harbi S; Bouabdallah R; Vey N; Santoro A; Chabannon C; Castagna L; Blaise D
    Cancer; 2015 Jun; 121(11):1809-16. PubMed ID: 25649994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intensive immunosuppression therapy for aplastic anemia associated with dyskeratosis congenita.
    Al-Rahawan MM; Giri N; Alter BP
    Int J Hematol; 2006 Apr; 83(3):275-6. PubMed ID: 16720563
    [No Abstract]   [Full Text] [Related]  

  • 54. Unrelated donor allogeneic hematopoietic cell transplantation is underused as a curative therapy in eligible patients from the United States.
    Yao S; Hahn T; Zhang Y; Haven D; Senneka M; Dunford L; Parsons S; Confer D; McCarthy PL
    Biol Blood Marrow Transplant; 2013 Oct; 19(10):1459-64. PubMed ID: 23811537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of Myelodysplastic Syndrome Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: A Study by the French Society of Bone Marrow Transplantation and Cell Therapies.
    Guièze R; Damaj G; Pereira B; Robin M; Chevallier P; Michallet M; Vigouroux S; Beguin Y; Blaise D; El Cheikh J; Roos-Weil D; Thiebaut A; Rohrlich PS; Huynh A; Cornillon J; Contentin N; Suarez F; Lioure B; Mohty M; Maillard N; Clement L; François S; Guillerm G; Yakoub-Agha I
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):240-247. PubMed ID: 26256942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allogeneic Hematopoietic Cell Transplantation in Patients with Primary Immunodeficiencies in Korea: Eleven-Year Experience in a Single Center.
    Yi ES; Choi YB; Lee NH; Lee JW; Sung KW; Koo HH; Kang ES; Kim YJ; Yoo KH
    J Clin Immunol; 2018 Oct; 38(7):757-766. PubMed ID: 30151618
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acceptance and feasibility of peripheral stem cell mobilisation compared to bone marrow collection from healthy unrelated donors.
    Ordemann R; Hölig K; Wagner K; Rautenberg U; Bornhäuser M; Kroschinsky F; Schäfer J; Schuler U; Ehninger G
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S25-8. PubMed ID: 9712488
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Dyskeratosis congenita: an update].
    Mialou V; Leblanc T; Peffault de Latour R; Dalle JH; Socié G
    Arch Pediatr; 2013 Mar; 20(3):299-306. PubMed ID: 23352883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ethical and policy lessons to be learned from a family with inherited bone marrow failure.
    Ross LF
    Am J Med Genet A; 2008 Nov; 146A(21):2715-8. PubMed ID: 18924227
    [No Abstract]   [Full Text] [Related]  

  • 60. Allogeneic Hematopoietic Stem Cell Transplantation in Thirty-Four Pediatric Cases of Mucopolysaccharidosis-A Ten-Year Report from the China Children Transplant Group.
    Wang J; Luan Z; Jiang H; Fang J; Qin M; Lee V; Chen J
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):2104-2108. PubMed ID: 27555533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.